Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dalamaga

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
Metabolism: Clinical and Experimental|October 22, 2013
Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndromeMaria Dalamaga, Konstantinos Karmaniolas, John Chamberland, et al.
Journal of Diabetes and Its Complications|August 8, 2021
The glycemic status determines the direction of the relationship between red cell distribution width and HbA1cDimitrios Tsilingiris, Konstantinos Makrilakis, Aikaterini Barmpagianni, et al.
International Journal of Molecular Sciences|January 11, 2024
The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and ControversiesMaria Dalamaga, Dimitrios Kounatidis, Dimitrios Tsilingiris, et al.
Biomolecules|January 21, 2022
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and PerspectivesNatalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) systemMaria Dalamaga, Konstantinos Karmaniolas, Athina Nikolaidou, et al.
Oncology|March 14, 2008
Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control studyMaria Dalamaga, Athina Nikolaidou, Konstantinos Karmaniolas, et al.
Leukemia & Lymphoma|September 23, 2014
Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosisVassiliki Nikolaou, Evangelia Papadavid, Afroditi Ekonomidi, et al.
Current Diabetes Reviews|January 3, 2021
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in ManagementNatalia G Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Obesity Reports|December 30, 2023
Obesity and Leukemia: Biological Mechanisms, Perspectives, and ChallengesDimitrios Tsilingiris, Natalia G Vallianou, Nikolaos Spyrou, et al.
Plos One|March 11, 2021
Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell LymphomaFani Karagianni, Christina Piperi, Vassiliki Mpakou, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
Metabolism: Clinical and Experimental|October 22, 2013
Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndromeMaria Dalamaga, Konstantinos Karmaniolas, John Chamberland, et al.
Journal of Diabetes and Its Complications|August 8, 2021
The glycemic status determines the direction of the relationship between red cell distribution width and HbA1cDimitrios Tsilingiris, Konstantinos Makrilakis, Aikaterini Barmpagianni, et al.
International Journal of Molecular Sciences|January 11, 2024
The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and ControversiesMaria Dalamaga, Dimitrios Kounatidis, Dimitrios Tsilingiris, et al.
Biomolecules|January 21, 2022
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and PerspectivesNatalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) systemMaria Dalamaga, Konstantinos Karmaniolas, Athina Nikolaidou, et al.
Oncology|March 14, 2008
Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control studyMaria Dalamaga, Athina Nikolaidou, Konstantinos Karmaniolas, et al.
Leukemia & Lymphoma|September 23, 2014
Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosisVassiliki Nikolaou, Evangelia Papadavid, Afroditi Ekonomidi, et al.
Current Diabetes Reviews|January 3, 2021
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in ManagementNatalia G Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Obesity Reports|December 30, 2023
Obesity and Leukemia: Biological Mechanisms, Perspectives, and ChallengesDimitrios Tsilingiris, Natalia G Vallianou, Nikolaos Spyrou, et al.
Plos One|March 11, 2021
Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell LymphomaFani Karagianni, Christina Piperi, Vassiliki Mpakou, et al.
Pageof 27